RAD 104
Alternative Names: F-18-labelled; RAD-104Latest Information Update: 14 Feb 2022
At a glance
- Originator Radiopharm Theranostics
- Class Diagnostic agents
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Kidney disorders
Most Recent Events
- 03 Feb 2022 Phase-II clinical trials in Kidney disorders (Diagnosis) in Australia (IV) (Radiopharm Theranostics pipeline; February 2022)